AGITG NABNEC: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas
Conference Paper
Full Text
Duke Authors
Cited Authors
- Khasraw, M; Hofman, MS; Chantrill, L; Pavlakis, N; Gebski, V; Gill, AJ; Markman, B; Yip, S; Gibbs, E; Karapetis, C; Wong, SF; Ransom, DT; Michael, M; Wilson, K; Simes, J; Lipton, L
Published Date
- September 1, 2017
Published In
Volume / Issue
- 28 /
Published By
Pages
- 2
Electronic International Standard Serial Number (EISSN)
- 1569-8041
International Standard Serial Number (ISSN)
- 0923-7534
Conference Name
- 42nd European-Society-for-Medical-Oncology Congress (ESMO)
Conference Location
- Madrid, SPAIN
Conference Start Date
- September 8, 2017
Conference End Date
- September 12, 2017